Cargando…

OR32-05 Lower Oxytocin Levels Are Associated with Lower Bone Mineral Density and Less Favorable Hip Geometry in Hypopituitary Men

Introduction: Hypopituitary patients are at risk for bone loss. Oxytocin (OT) and vasopressin (VP) are hypothalamic-posterior pituitary hormones with opposing actions on bone (anabolic and catabolic, respectively). Whether OT and/or VP contribute to impaired bone homeostasis in hypopituitarism is un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maso, Ana Aulinas, Guarda, Francisco J, Yu, Elaine Wei-Yin, Haines, Melanie S, Asanza, Elisa, Silva, Lisseth, Tritos, Nicholas A, Verbalis, Joseph G, Miller, Karen Klahr, Lawson, Elizabeth Austen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209392/ http://dx.doi.org/10.1210/jendso/bvaa046.350

Ejemplares similares

SAT-442 Endogenous Oxytocin Response to Food Intake in Anorexia Nervosa
por: Aulinas, Ana, et al.
Publicado: (2019)

PMON58 Endogenous Oxytocin Response to Food Intake in Avoidant/Restrictive Food Intake Disorder Compared to Healthy Controls
por: Aulinas, Ana, et al.
Publicado: (2022)

Oxytocin Levels in Response to Pituitary Provocation Tests in Healthy Volunteers
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

SAT-441 Oxytocin Levels Are Associated with Psychopathology in Restricting but Not Binge-Purge Subtype of Anorexia Nervosa
por: Galbiati, Francesca, et al.
Publicado: (2019)

THU115 Sex-Specific And Shared Associations Between Vasopressin Levels And Body Composition In Adults With Obesity
por: Galbiati, Francesca, et al.
Publicado: (2023)

SUN-300 Improvement in Cardiovascular Risk Factors in Long Term Follow up of Hypopituitary Septagenarian and Octagenarian Patients
por: Rosa, Isabella Naves, et al.
Publicado: (2020)

MON-286 Peak Stimulated Growth Hormone Is Lower in Subjects with Nonalcoholic Fatty Liver Disease Than Controls of Similar Sex, Age and BMI
por: Dichtel, Laura E, et al.
Publicado: (2020)

Relationship Between Oxytocin Levels and Brain Volume in Anorexia Nervosa Compared to Healthy Controls
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

ODP643 Metabolic Effects of Growth Hormone Replacement in Craniopharyngioma and Pituitary Adenoma Patients: Analysis of the Hypopituitary Control and Complications Study (HypoCCS) Database
por: Cooper, Odelia, et al.
Publicado: (2022)

MON-425 SIADH with Epistaxis: Rule out Esthesioneuroblastoma
por: Diamond, Samantha, et al.
Publicado: (2019)

Changes in Quality of Life After Long-Term Biochemical Control of Acromegaly
por: Kimball, Allison, et al.
Publicado: (2021)

Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy
por: Yu, Xiaoling, et al.
Publicado: (2021)

ODP576 A pilot randomized clinical trial of intranasal oxytocin to promote weight loss in children, adolescents, and adults with hypothalamic obesity
por: Bamba, Vaneeta, et al.
Publicado: (2022)

ODP370 Disconnect Between Hypothalamic-Pituitary-Adrenal Activity and Amygdala Activation Using Novel Neuroimaging Fear Paradigm in Youth With Avoidant/Restrictive Food Intake Disorder
por: Sailer, Clara O, et al.
Publicado: (2022)

THU033 High Prevalence Of Venous Thrombotic Events In Cushing’s Syndrome: Data From ERCUSYN
por: Isand, Kristina, et al.
Publicado: (2023)

OR01-05 Growth Hormone Action In Somatostatin Neurons Regulates Anxiety And Fear Memory
por: dos Santos, Willian O, et al.
Publicado: (2023)

SUN-455 Abnormalities in Bone Microarchitecture of Women with Active Acromegaly Using HR-pQCT
por: Paes Batista da Silva, Paula, et al.
Publicado: (2019)

OR32-2 Alpha Klotho as a Marker of Disease Activity in Acromegaly
por: Schweizer, Junia, et al.
Publicado: (2019)

OR06-05 Inadequate High Mitochondrial ATP-Synthesis Explains “Non-Fatty-Liver” in Patients with Acromegaly
por: Fellinger, Paul, et al.
Publicado: (2020)

Olfactory Performance in Youth With Full and Subthreshold Avoidant/Restrictive Food Intake Disorder
por: Stull, Madeline Rogers, et al.
Publicado: (2021)

OR32-1 Endocrine Manifestations of Erdheim-Chester Disease: The Mayo Clinic Experience
por: Hurtado, Maria, et al.
Publicado: (2019)

Appetite-Regulating Hormone Ghrelin Predicts Decision-Making in Healthy Controls but Not Individuals With Low-Weight Eating Disorders
por: Shiraliyeva, Naila, et al.
Publicado: (2021)

Oral Octreotide Capsules Lowered Incidence and Improved Severity of Acromegaly Symptoms Compared to Injectable Somatostatin Receptor Ligands—Results From the MPOWERED Trial
por: Biermasz, Nienke, et al.
Publicado: (2021)

OR32-3 Kisspeptin- a Novel Clinical Test of Hypothalamic Function in Men with Hypogonadotrophic Hypogonadism
por: Phylactou, Maria, et al.
Publicado: (2019)

OR17-05 Lysine Demethylase KDM1A And Ectopic Expression Of GIP-Receptor In Somatotropinomas Of Patients With Paradoxical Response To Oral Glucose
por: Chasseloup, Fanny, et al.
Publicado: (2023)

OR32-5 Associations between Circulation Lipocalin 2, Body Composition, and Glucose Metabolism in Active Acromegaly
por: Zhang, Yan, et al.
Publicado: (2019)

OR32-02 Immune Checkpoint Inhibitor-Induced Hypophysitis Is Associated with Improved Overall Survival in Cancer Patients
por: Kotwal, Anupam, et al.
Publicado: (2020)

PYY Levels and Relationship to Appetite Across Different Presentations of Anorexia Nervosa
por: Muhammed, Maged, et al.
Publicado: (2021)

Expression of IGF-1, IGF-1 Receptor and Growth Hormone Receptor in Hepatic Tissue in Adults Across the Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
por: Dichtel, Laura E, et al.
Publicado: (2021)

OR16-05 Single-Cell Sequencing Identifies Novel Regulators of Thyrotrope Populations and POU1F1-Independent Thyroid-Stimulating Hormone Expression
por: Cheung, Leonard, et al.
Publicado: (2020)

OR20-05 Generation Of CDH23-mutated Pituitary Neuroendocrine Tumor Organoids From Induced Pluripotent Stem Cells To Model Cushing’s Disease Pathogenesis
por: Chakrabarti, Jayati, et al.
Publicado: (2023)

SAT-420 Gonadotropin-Releasing Hormone Stimulates Luteinizing Hormone Exocytosis without Elevating Lhb Expression
por: Janjic, Marija, et al.
Publicado: (2019)

PMON165 Favorable Liver Safety Profile of the Selective Glucocorticoid Receptor Modulator Relacorilant in Healthy and Hepatically Impaired Adults and in Patients with Cushing Syndrome
por: Moraitis, Andreas, et al.
Publicado: (2022)

OR17-01 Novel Provocation Test With MDMA (‘Ecstasy’) Reveals Oxytocin Deficiency As A New Pituitary Entity In Patients With Central Diabetes Insipidus - A Randomized Placebo-Controlled Trial
por: Atila, Cihan, et al.
Publicado: (2023)

OR32-04 Dynamic Interactions Between Luteinizing Hormone and Testosterone in Healthy Community-Dwelling Men: Impact by Age and Body Composition
por: Roelfsema, Ferdinand, et al.
Publicado: (2020)

SUN-303 Effects of Open-Label, Adjunctive Ganaxalone Treatment on Resistant Depression in Postmenopausal Women: A Pilot Study
por: Dichtel, Laura E, et al.
Publicado: (2020)

OR32-6 Pre-Surgical GH Levels Predict the Risk of Morphometric Vertebral Fracture, Which Is an Early and Frequent Event in the Natural History of Acromegaly
por: Frara, Stefano, et al.
Publicado: (2019)

FRI355 Hypokalemia-induced Nephrogenic Diabetes Insipidus In A Patient With Medullary Thyroid Carcinoma And Paraneoplastic Cushing’s Syndrome
por: Jhawar, Sakshi, et al.
Publicado: (2023)

OR32-4 Diagnostic Performance of Macimorelin vs the Insulin Tolerance Test (ITT) in 140 Patients at Varying Growth Hormone (GH) Cutpoints: A Post Hoc Analysis
por: Garcia, Jose, et al.
Publicado: (2019)

OR32-06 Opportunistic Assessment of Pituitary Gland with Routine MRI and PET/CT Can Guide in Earlier and Increased Identification of Hypophysitis in Patients Treated with Combination Checkpoint Inhibitors
por: Galligan, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u607ind01uiuibk68r02oa5b9m